411 POSTER A phase I, open-label, dose-escalation study of the safety and pharmacology of MetMAb, a monovalent antagonist antibody to the receptor c-Met, administered IV in patients with locally advanced or metastatic solid tumors
R. Salgia, A. Peterson, S. Eppler, W. Yu, B. Polite, D. Geary, E. Wesolowski, M. LaRosiliere, M. Ratain, M. SovakVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)72345-0
File:
PDF, 61 KB
english, 2008